Job Recruitment Website - Ranking of immigration countries - A 55-year-old nurse in Germany died of cerebral thrombosis again. Is there really something wrong with the vaccine?

A 55-year-old nurse in Germany died of cerebral thrombosis again. Is there really something wrong with the vaccine?

According to foreign media reports, a 55-year-old nurse from Kempten Hospital in Argonne was confirmed dead after being vaccinated with AstraZeneca vaccine on March 20th. This is the 14 case of cerebral venous thrombosis caused by AstraZeneca vaccine in Germany, and 13 of the 14 cases are women aged 20 to 63, so AstraZeneca vaccine has once again successfully attracted the attention of European media. Because AstraZeneca vaccine has caused many deaths in Europe, many European countries have stopped taking AstraZeneca vaccine. Although there is no evidence that these cases are directly caused by AstraZeneca vaccine, they are all symptoms caused by AstraZeneca vaccine, so the safety of AstraZeneca vaccine is still worthy of re-investigation.

AstraZeneca vaccine is a COVID-19 vaccine jointly developed by Oxford University and AstraZeneca Pharmaceutical Company. AstraZeneca vaccine has achieved some remarkable results in the initial stage of marketing, but with the increase of users, the side effects of AstraZeneca vaccine have also been reflected.

In March 2020, due to serious adverse reactions after AstraZeneca vaccination in Austria, Austria announced the suspension of AstraZeneca vaccination, followed by Ireland and the Netherlands. As the problem gradually emerged, Denmark, the Netherlands, Norway, Iceland, Bulgaria and Ireland finally decided to suspend AstraZeneca vaccination nationwide, while Austria, Italy, Estonia and other countries announced the suspension of some batches of AstraZeneca vaccination.

Germany had previously announced a moratorium on AstraZeneca vaccination in China, but after a preliminary investigation, the European Medicines Agency gave it? The advantages outweigh the disadvantages? After the evaluation, Germany immediately resumed the inoculation of AstraZeneca vaccine, and with the exposure of this death case, Germany thought it necessary to re-evaluate AstraZeneca vaccine.